Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - TOTAL ASSETS
Total Assets IKT - Inhibikase Therapeutics, Inc.
14.5 M
LAST VALUE
-41.56%
2 YEAR CAGR
38.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR